As a subsidiary of WuXi AppTec, MilestonePharma is committed to building an integrated drug quality research technology platform that complies with global pharmaceutical regulations, striving to become the industry leader with the most comprehensive capabilities, strongest technology, and best quality. Headquartered in Nanjing, the company has CNAS-certified laboratories in Jiangbei New Area of Nanjing and Pudong New Area of Shanghai, both of which successfully passed the FDA on-site audit in 2023. Focusing on drug quality standard research, we have built a comprehensive pharmaceutical research platform and a drug analysis platform, providing CMC pharmaceutical research services, raw and auxiliary materials registration services, as well as various advantageous technology platforms, including pharmaceutical packaging materials E&L research, nitrosamine/gene toxin/trace impurity research, separation, purification and structural identification, pre-formulation research, formulation development and dissolution release, in vitro bioequivalence evaluation, analytical method development and validation services. MilestonePharma has provided pharmaceutical-related services to more than 2,500 pharmaceutical companies and biotechnology companies worldwide, successfully delivered more than 7,000 projects, helped and witnessed the successful application of customers, and accelerated the launch and internationalization of innovative products.